The growth of this market is influenced by a number of factors, such as the increasing penetration of smartphones, growing penetration of 3G and 4G networks, rising focus on patient-centric healthcare delivery, and the benefits offered by urgent care apps.
The global dental sterilization market is projected to reach USD 1.48 billion by 2023 from an estimated USD 1.08 billion in 2018, at a CAGR of 6.6%.
The global Endoscopy Equipment Market is projected to reach USD 34.82 Billion by 2022 from an estimated USD 25.58 Billion in 2017, at a CAGR of 6.4%
The global Fertility Test Market is expected to reach USD 772.9 million by 2027 from USD 411.8 million in 2018, at a CAGR of 7.2%
The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 9.42 billion in 2017, at a CAGR of 10.6% during the forecast period.
The global guidewire market is projected to reach USD 764.0 Million by 2022 from USD 582.5 Million in 2016, at a CAGR of 4.8%.
The global medical device security market was valued at USD 4.04 Billion in 2017 and is projected to reach USD 6.59 Billion by 2023, at a CAGR of 8.6% during the forecast period. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.
The growth in this market is mainly attributed to factors such as growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population, and rising labor cost.
The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%.
The bioabsorbable stent market comprises of a fewer number of players. Prominent players in the bioabsorbable stent market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.